INNOVATIVE THERAPY DAYS

October 9th - 10th, 2025, Kursaal - Besançon

Daniele Noël, CEO of OBBI, will attend the Innovative Therapies Days 2025 in Besançon—an event bringing together key players in advanced therapies. She will showcase OBBI’s unique expertise in organoid and extracellular vesicle bioproduction, and explore new partnerships to accelerate biotherapeutic innovation.

News & events

We are pleased to announce that Daniele Noel, CEO of OBBI (Occitanie Biotherapy-Bioproduction Integrator), will attend the Innovative Therapies Days 2025, a key event fostering dialogue between academic, clinical, and industrial stakeholders in advanced therapies.

This event provides a unique opportunity to share OBBI’s dual expertise in organoid and extracellular vesicle (EV) bioproduction—two cutting-edge technologies with transformative potential in personalized medicine, regenerative therapies, and drug development.

Through OBBI, Inserm and regional partners in Montpellier and Toulouse are advancing a new generation of biotherapeutics by providing industry-grade platforms, innovative services, and collaborative opportunities. Daniele Noel will represent this strategic initiative and connect with leaders shaping the future of healthcare innovation.

Share with :

INNOVATIVE THERAPY DAYS

News & events

10th Bioproduction Congress in Lyon

Montserrat Bosch Grau, Chief Business Officer at OBBI, will attend the 10th Bioproduction Congress in Lyon—the leading European event for biomanufacturing. This will be an opportunity to present OBBI’s expertise in organoid and extracellular vesicle bioproduction and to connect with...

News & events

Biotherapy Days 2026

Dr. Danièle Noël, Research Director at IRMB, will be speaking at Biotherapy Days 2026 in Toulouse—the premier gathering for the biotherapy and bioproduction community in Occitanie. As part of her talk, she will present the OBBI initiative, offering valuable visibility...